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Abstract
Background: Spondyloarthritis often affects young people, typically in their working years. The aim of our study was to
investigate work productivity and its relationship with disease activity and physical functioning in Italian patients with
axial spondyloarthritis (axSpA) with chronic back pain (CBP) for ≥3 months and ≤2 years, and onset < 45 years of age.
Methods: Baseline absenteeism, presenteeism, work productivity loss (assessed by the Work Productivity and Activity
Impairment questionnaire (WPAI)), and disease activity (assessed by the Bath Ankylosing Spondylitis Disease Activity
Index (BASDAI)/Ankylosing Spondylitis Disease Activity Score (ASDAS)) and functional ability (assessed by the Bath
Ankylosing Spondylitis Disease Functional Index (BASFI)) of patients with axSpA (rheumatologist’s diagnosis) included in
the Italian section of the Spondyloarthritis Caught Early (SPACE) cohort were collected. Multivariate linear regression
analysis was used to evaluate the associations between work productivity and disease activity/physical functioning.
Results: Absenteeism in 51 patients with axSpA was low (8.3 %). A decrease in work productivity was related to an
increase in disease activity. Disease activity was strongly correlated with absenteeism (p < 0.01), presenteeism (p < 0.01)
and work productivity loss (p < 0.001). In addition, decreased work productivity was related to a decrease in functional
ability. Physical functioning was correlated with absenteeism (p < 0.001), presenteeism (p < 0.05) and work productivity
loss (p < 0.001).
Conclusions: Impairment of work productivity was correlated with disease activity and physical functioning in Italian
patients with axSpA with CBP for ≥3 months and ≤2 years, with onset <45 years of age.
Keywords: Spondyloarthritis, Work, Back pain, Disease activity
Background
Spondyloarthritis (SpA) are a group of chronic inflam-
matory rheumatic diseases that share several clinical
characteristics. They can be subdivided into axial SpA
(axSpA) or peripheral SpA depending on the predominant
musculoskeletal site involved [1]. Patients with axSpA
can be further subdivided into two groups: patients
with radiographic evidence of sacroiliitis (ankylosing
spondylitis, AS) or without radiographic sacroiliitis
(non-radiographic axSpA, nr-axSpA). Patients with axSpA
often suffer from impaired function, activity limitations
and decreased health-related quality of life (HRQoL)
[2–4]. AxSpA usually occurs during young adulthood,
before the third decade [5]; thus, function impairment
and activity limitations can have important socioeco-
nomic consequences because they affect patients who
have just started working. The work participation of
axSpA patients with longstanding disease has previ-
ously been reported in several studies, which showed
correlation between decreased work productivity and
increased disease-related sick leave [6–8]. Limitations
in physical functioning are also strongly associated with
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work restrictions in patients with axSpA [2, 6]. Besides
limitations in work productivity when performing paid
work, patients with axSpA also seem to be limited in
performing daily activities such as taking care of the
family, studying or housekeeping [6].
A study focusing on three European countries
(Netherlands, Belgium and France) showed that the
work status and productivity of patients with AS differ
among these countries [9], decreasing the generalizability
of the correlation between work productivity and dis-
ease activity or physical functioning in patients with
axSpA as identified in previous studies. The prevalence
of axSpA in Italy is 1.06 % [10] and the prevalence of
nr-axSpA is estimated to be 0.35 % [11]. Few data on
work productivity in Italian patients with axSpA are
available [12]; it is therefore important to get a clear
picture on how this disease impacts the work product-
ivity. The aim of our study was to investigate work
productivity and its relationship with disease activity
and physical functioning in Italian patients with short-
term chronic back pain (CBP) who participated in the
Italian section of the Spondyloarthritis Caught Early
(SPACE) cohort. In particular presenteism, absenteeism,
and work productivity loss (WPL) were considered.
Presenteism represents the reduced work productivity
due to disease; absenteeism is the percentage of hours
missed due to disease; WPL gives an indication of the
total work impairment due to disease.
Methods
Patients
Patients who were at least 16 years old, suffering from
CBP (≥3 months, ≤2 years, onset < 45 years of age) of
unknown origin and referred to a rheumatologist were
included in the Italian section of the SPACE cohort.
This is an ongoing observational cohort study, which
was originally launched at the Leiden University Med-
ical Centre (LUMC) in January 2009.
In March 2012 the SpA study group of the Rheumatol-
ogy Unit at the University of Padua opened an Italian
branch of the SPACE cohort. Eligible patients underwent
physical examination, laboratory tests, radiographic im-
aging and magnetic resonance imaging (MRI) of the
sacroiliac joints and spine according to a standardized
protocol. In addition, patients completed questionnaires
on disease activity, physical functioning, pain and im-
pairment due to the disease, and work productivity. The
SPACE cohort has been extensively described in a previ-
ous publication [13]. An experienced rheumatologist
diagnosed axSpA. Only baseline data were used in these
analyses. At this time point, all patients were treated
with non-steroidal anti-inflammatory drugs. No patients
were treated with synthetic or biological disease modi-
fying anti-rheumatic drugs.
Questionnaires
The Work Productivity and Activity Impairment (WPAI)
questionnaire is validated to assess the impact of a disease
(here axSpA) on work productivity and on other daily
activities [14, 15]. The Italian version of the WPAI was
used to obtain the data in our study (from http://
www.reillyassociates.net/WPAI_Translations.html) [16].
By using six items, the questionnaire measures: (Ques-
tion (Q)1) patients’ employment status; (Q2) number of
hours missed at work due to axSpA; (Q3) number of
hours missed at work due to due to other reasons; (Q4)
number of hours worked effectively according to the
patient’s own judgment; (Q5) degree of disease influ-
ence on work productivity, according to the patient;
and (Q6) degree of disease influence on activities not
related to work, according to the patient [13].
The WPAI questionnaire allows the calculation of
absenteeism, presenteeism and work productivity loss
(WPL). Presenteeism represents the reduced work
productivity due to disease, which is rated on a 0–
100 % numeric scale, and is calculated as the degree of
disease influence on work productivity/10 (question
(Q)5). Absenteeism is the percentage of hours missed
due to disease (and not due to other reasons) and is
calculated as follows the number of hours missed at
work due to axSpA (Q2)/(number of hours missed at
work due to axSpA (Q2) + number of hours worked
effectively (Q4)) [14]. The WPL gives an indication on
the total work impairment due to disease and is derived
from presenteeism and absenteeism as follows: absen-
teeism + ((1-Absenteism) × (Presenteeism)). All scores
are to be multiplied by 100 to be expressed as percentages.
The higher the presenteeism, absenteeism or WPL scores,
the greater the work impairment is due to disease.
It has to be underlined that as patients could do both
paid work and other daily activities, they reported separ-
ately on the WPAI items for paid work (in the form of
employee or self-employment) and/or daily activities (in
the form of domestic work, studying, voluntary work or
taking care of family members). The disease activity and
physical functioning of patients were assessed with self-
reported questionnaires: the Bath Ankylosing Spondylitis
Disease Activity Index (BASDAI), the Bath Ankylosing
Spondylitis Functional Index (BASFI) and the Ankylosing
Spondylitis disease activity score (ASDAS), which com-
bines items from the BASDAI, patient global assessment
and serum C-reactive protein (CRP) [17]. Four ASDAS
categories were defined: inactive disease (ASDAS <1.3),
moderate disease activity (ASDAS ≥1.3 and <2.1), high
disease activity (ASDAS ≥2.1 and ≤3.5) and very high dis-
ease activity (ASDAS >3.5) [18]. BASDAI and BASFI con-
tinuous scores were converted into dichotomous scores.
BASDAI <4 indicated low disease activity and BASDAI ≥4
indicated high disease activity [17]. As there is no BASFI
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score for impaired and unimpaired physical functioning,
we arbitrarily choose a BASFI score ≥2.5 to indicate im-
paired physical functioning.
Statistical analyses
Patient characteristics were reported by descriptive
statistics. The Mann-Whitney test was used to evaluate
the association between work productivity and disease
activity (evaluated by BASDAI) and physical functioning.
The Kruskal-Wallis test was used to evaluate the rela-
tionship between work productivity and the four ASDAS
states. Multivariate linear regression analyses were per-
formed to evaluate the association of BASDAI, ASDAS
and BASFI continuous scores with presenteeism, absen-
teeism and WPL, adjusted for age, gender, HLA-B27
positivity and duration of CBP. SPSS 21 was used to
perform statistical analysis.
Results
Out of 51 patients enrolled in the study, 100 % fulfilled
the ASAS criteria for axSpA; 4 (7.8 %) were diagnosed
as having AS and 47 (92.2 %) as having nr-axSpA. Mean
age at CBP onset was 29.7 (SD ± 8.7) years, 21 patients
(41.2 %) were men and 16 patients (31.4 %) were HLA-
B27 positive. All 51 patients had at least two features of
SpA and the maximum disease activity and physical
functioning scores were 9.1 (BASDAI), 4.2 (ASDAS) and
8.9 (BASFI). Other patient characteristics, including
work status and mean scores for disease activity and
physical functioning, are reported in Table 1. A detailed
description of patient characteristics has been published
before [19].
Work productivity
When looking at all 51 patients, they worked 36.4
(±13.9) hours and missed 4.2 (± 8.4) hours per week due
to axSpA, presenteeism was 28.6 %, absenteeism 8.3 %
and WPL 33.7 %. Table 2 shows the hours worked and
missed due to axSpA, presenteeism, absenteeism and
WPL of patients with paid jobs (employed and self-
employed) or performing voluntary work, domestic
work, care of family and/or studying. There were 35
patients (68.6 %) in paid work; 6 of them combined paid
work with voluntary work (n = 1), domestic work (n = 1),
care of the family (n = 2), studying (n = 1) or a combin-
ation (n = 1). Patients spent less time (27.6 hours) in daily
activities compared to income-earning jobs (35.7 hours).
There was no difference between patients involved in paid
work and other daily activities in the number of missed
hours/week due to the disease. However, while patients in
paid work missed <4 hours/week, patients doing domestic
work missed >6 hours/week. Patients with paid work had
greater productivity loss due to disease (presenteeism =
32.6 % vs 18.6 %, p = 0.031). Absenteeism was in general
relatively low in this cohort (7.9 % in income-earning pa-
tients and 8.3 % in patients performing other activities).
Relationship between work productivity and disease
activity or physical functioning
We identified decrease in work productivity alongside
increased disease activity (ASDAS). Hours missed at
work (p = 0.087), absenteeism (p = 0.050), presenteeism
(p = 0.205) and WPL (p = 0.012) increased with the pro-
gressive increase in disease activity (ASDAS). Patients
with very high disease activity (ASDAS ≥3.5) worked on
average 10 hours less than patients with inactive disease
(ASDAS ≤1.3) (p = 0.122). Presenteeism (p = 0.049) and
WPL (p = 0.007) were significantly increased in patients
with BASDAI ≥4 compared to patients with BASDAI <4
(Table 2).
Although the number of hours worked were similar
(p = 0.737), hours missed at work (p = 0.021), the degree
on disease influence on daily activities (Q6; p = 0.020),
absenteeism (p = 0.014), presenteeism (p = 0.010) and
WPL (p = 0.000) were significantly higher in patients
Table 1 Baseline characteristics of Italian patients with axSpA
included in the SPACE cohort (n = 51)
Characteristic Value
Age of onset back pain, mean (± SD) 29.7 (± 8.7)
Male, n 21 (41.2 %)
Marital state
- Married 15 (45.1 %)
- Unmarried (with partner) 13 (25.5 %)
- Unmarried (without partner) 23 (29.4 %)
Education level
- Only primary school 3 (5.9 %)
- Secondary education 28 (54.9 %)
- University education 20 (39.2 %)
Duration (months) back pain, mean (± SD) 12.9 (± 5.9)
Work status
- Employed, n 28 (54.9 %)
- Self employed, n 7 (13.7 %)
- Domestic work, n 8 (15.7 %)
- Studying, n 11 (21.6 %)
- Voluntary work, n 2 (3.9 %)
- Care taking of family members, n 3 (5.9 %)
ASDAS, mean (± SD) 2.3 (± 1.0)
BASDAI, mean (± SD) 4.5 (± 2.6)
BASFI, mean (± SD) 1.7 (± 2.1)
axSpA axial spondyloarthritis, SPACE Spondyloarthritis Caught Early, ASDAS
Ankylosing Spondylitis Disease Activity Score, BASDAI Bath Ankylosing
Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis
Functional Index
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with low BASFI scores (<2.5) compared to patients with
high BASFI scores (≥2.5).
Table 3 shows that the associations between work
productivity and disease activity and physical functioning
were statistically significant on linear regression analyses.
Results were adjusted for age, gender, HLA-B27 positivity,
duration of CBP. There was no interaction between
marital status or educational level and work productivity
or BASDAI/ASDAS.
Discussion
In this study we found work productivity impairment to
be correlated to both disease activity and physical func-
tioning in Italian patients with axSpA with CBP ≥3 months
and ≤2 years, with onset < 45 years of age. In addition,
absenteeism was very low compared to that in patients
in other countries.
In our study, patients with axSpA with income-earning
jobs worked 2.2 hours/week less than the general Italian
population with income-earning jobs, who work 36 hours/
week (as reported on http://dati.istat.it (June 2015)). We
identified 7.9 % absenteeism in patients with paid work,
which is similar to the sick leave in the general Italian
population (8.4 %). However, the rate of sick leave in
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Hours missed per week















Paid work 35.7 (± 12.9) 3.4 (± 6.8) 2.1 (± 3.5) 4.1 (± 2.8) 7.9 (± 14.0) 32.6 (± 31.2)* 36.6 (± 30.0)
- Employed 33.8 (± 9.4) 3.6 (± 7.4) 2.4 (± 3.8) 4.2 (± 2.9)
- Self employed 43.6 (± 21.4) 2.6 (± 3.3) 1.0 (± 1.7) 3.4 (± 2.4)
Other daily activities 27.6 (± 12.4) 4.3 (± 9.4) 0.6 (± 1.5) 4.6 (± 3.5) 8.3 (± 13.9) 18.6 (± 28.8)* 25.6 (± 28.5)
- Domestic work 29.1 (± 10.9) 6.4 (± 13.8) 0.8 (± 2.1) 6.1 (± 3.7)
- Studying 29.0 (± 13.0) 3.7 (± 6.7) 0.4 (± 0.9) 3.6 (± 3.4)
- Voluntary work 6.0 (0) - 3.0 (0) 0.5 (± 0.7)
- Taking care of
family members
14.7 (± 9.5) 1.0 (± 1.7) - 4.3 (± 2.9)
ASDAS score (disease activity)
< 1.3 (inactive) 41.4 (± 9.6) 0.8 (± 2.1) 2.8 (± 4.7) 2.6 (± 2.8) 1.7 (± 4.0)* 14.5 (± 21.1) 15.3 (± 22.2)*
1.3–2.1 (moderate) 33.5 (± 18.9) 3.0 (± 6.4) 1.7 (± 3.1) 2.9 (± 2.7)* 5.7 (± 10.0)* 20.9 (± 25.1) 26.3 (± 23.0)*
2.1 − 3.5 (high) 36.9 (± 13.5) 3.3 (± 5.4) 1.2 (± 2.2) 5.2 (± 2.6)* 7.3 (± 10.9)* 32.2 (± 31.2) 36.9 (± 30.1)*
≥ 3.5 (very high) 31.2 (± 10.2) 16.0 (± 16.7) - 7.0 (± 3.7) 29.2 (± 24.6)* 55.0 (± 44.6) 68.3 (± 28.8)*
BASDAI score (disease activity)
< 4 (low) 37.6 (± 14.9) 2.3 (± 5.0) 1.9 (± 3.7) 2.5 (± 2.5)*** 4.4 (± 8.3) 17.4 (± 24.0)* 20.5 (± 24.4)*
≥ 4 (high) 35.5 (± 13.1) 5.8 (± 10.2) 1.2 (± 2.3) 5.8 (± 2.8)*** 11.5 (± 17.0) 37.9 (± 34.1)* 44.5 (± 30.9)*
BASFI score (physical function)
< 2.5 (low) 35.9 (± 13.5) 2.2 (± 4.4)* 1.8 (± 3.3) 3.6 (± 2.9)*** 4.8 (± 8.5)* 21.3 (± 26.2)** 24.8 (± 26.3)**
≥ 2.5 (high) 38.2 (± 15.3) 10.8 (± 13.8)* 0.7 (± 2.0) 6.9 (± 2.6)*** 19.6 (± 21.8)* 52.5 (± 36.2)** 62.5 (± 24.7)**
axSpA axial spondyloarthritis, ASDAS Ankylosing Spondylitis Disease Activity Score, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath
Ankylosing Spondylitis Functional Index; *p < 0.05; **p < 0.01; ***p < 0.001
Table 3 Relationship between work productivity and disease
activity and functional ability in patients with early axSpA
R2 ß-estimated 95 % CI
Absenteeism
ASDAS 0.30 6.08 2.8–10.8
BASDAI 0.29 2.65 1.1–4.3
BASFI 0.51 4.32 2.9–5.8
Presenteeism
ASDAS 0.28 16.04 7.1–25.0
BASDAI 0.25 5.80 2.2–9.4
BASFI 0.16 4.62 0.4–8.9
Work productivity loss
ASDAS 0.36 18.86 10.8–27.0
BASDAI 0.34 7.12 3.9–10.4
BASFI 0.29 7.31 3.6–11.1
Data are adjusted for age, gender, human leucocyte antigen (HLA)-B27
positivity and duration of chronic back pain. axSp, axial spondyloarthritis,
ASDAS Ankylosing Spondylitis disease activity score, BASDAI Bath Ankylosing
Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis
Functional Index, CI confidence interval
de Hooge et al. Arthritis Research & Therapy  (2016) 18:265 Page 4 of 6
our patients with axSpA is much lower than reported
in other studies. A Dutch study in patients with early
SpA (with <5 years disease duration) reported a rate of
28 % for sick leave in the Amsterdam area [20], a rate
almost 7 times higher than in the general population in
Amsterdam and 3.5 times higher compared to our data.
This difference may be due to the higher average age
and the longer disease duration in these Dutch patients
with respect to our patients. Moreover, 74 % of Dutch
patients had a defined diagnosis of AS, while our pa-
tients had nr-axSpA in 92.2 % of cases.
Sick leave rates reported in the literature largely vary
between several countries with 47 % in Belgium, 48 % in
France and 52 % in the Netherlands, while the sick leave
rate was reported as 28 % in Sweden and 16 % in the
UK [9, 21, 22]. It has to be pointed out that the great
majority of these studies were focused on patients with
longstanding AS. In this severely affected patient group,
the sick leave rate was expected to be higher due to the
proven effect of AS on work productivity [23]. Like
absenteeism, presenteeism seems to be lower in our pa-
tients compared to other studies. The few available data
on presenteeism show rates of 41 % in patients with
early SpA and 45 % in patients with AS of 10–18 years
disease duration, while we identified a presenteeism rate
of 32.6 % in patients with early axSpA [23]. This indi-
cates that Italian patients with early axSpA have reduced
work productivity, but the disease does not lead to more
sick leave, compared to the general Italian population.
Several studies show correlation between WPL and in-
creased disease activity and decreased physical function-
ing [9, 24]. In addition, Haglund et al. found BASDAI
and BASFI not only to be correlated with presenteeism
but also with activity impairment going beyond patients’
paid work [25]. Although those studies focused on
patients with longstanding AS, the results of our study
were similar, supporting the idea that disease activity
more than disease duration can impact on work ability
and productivity.
This study was based on a small sample size. Even
though the number of patients was relatively small the
authors found the results to be of importance, as there
are no available data on this matter in Italy. In the
future, a longitudinal study could be conducted to more
intensively investigate the course of disease activity and
its relationship with work productivity. Another limita-
tion of our study was the use of self-report question-
naires to determine disease activity, physical functioning
and work productivity.
Self-report questionnaires tend to give a biased view,
which can lead to either underestimation or overesti-
mation of the findings. Nevertheless, the validity of these
questionnaires was tested and considered good [17].
Therefore validated, standardized questionnaires are often
used in these studies and are the preferred tool to assess
disease outcome. The strength of our study was the ab-
sence of bias due to non-responders, as all 51 patients
reported back.
Conclusions
In conclusion, our analyses showed that absenteeism
and presenteeism rates were lower in Italian patients
with axSpA with ≤2 years disease duration compared to
the rates in other European countries. In addition, in
these Italian patients with early axSpA, work productivity
correlated with disease activity and physical functioning,
as previously was found in in several European studies of
patients with longstanding AS.
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